Siglec-1-targeted nanobodies restrict HIV-1 transmission and infection of dendritic cells
Shirley Man, Alsya J. Affandi, Hendrik J. Brink, John L. van Hamme, Veronique A. L. Konijn, Joeke G. C. Stolwijk, Joke M. M. den Haan, Neeltje A. Kootstra, Teunis B. H. Geijtenbeek · 2026
Read Siglec-1-targeted nanobodies restrict HIV-1 transmission and infection of dendritic cells by Shirley Man, Alsya J. Affandi, Hendrik J. Brink, John L. van Hamme, Veronique A. L. Konijn, Joeke G. C. Stolwijk, Joke M. M. den Haan, Neeltje A. Kootstra, Teunis B. H. Geijtenbeek (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13483292.txt.
Description
Shirley Man and co-authors present a 2026 study of tiny antibodies that block HIV at its first handshake with immune sentries. Dendritic cells grab the virus through a surface catcher called Siglec-1, then ferry it to the T cells it infects. The team built single-domain antibodies, called nanobodies, that plug that catcher.
In catcher-rich test cells the nanobodies stopped virus binding and handoff. In real dendritic cells they stirred no unwanted immune activation, a clean safety sign. One lead, named 2C2, blocked both binding and outright infection of the sentries. Handoff to T cells died away whether the virus needed to copy itself first or not. Guarding the host's own catcher, rather than chasing the virus, may dodge the escape tricks that sink virus-targeted blockers.
Catalog record
| CREATOR | Shirley Man, Alsya J. Affandi, Hendrik J. Brink, John L. van Hamme, Veronique A. L. Konijn, Joeke G. C. Stolwijk, Joke M. M. den Haan, Neeltje A. Kootstra, Teunis B. H. Geijtenbeek |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 39 KB |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |